Diabetes is a fast growing chronic metabolic disorder around the world. Dipeptidyl peptidase-
4 (DPP-4) is a new promising target during type 2 diabetes glycemic control. Thus, a number …

Proteases are enzymes that hydrolyze peptide bonds in proteins and peptides; thus, they
control virtually all biological processes. Our understanding of protease function has …

Abstract Type 2 Diabetes Mellitus (T2DM) is one of the highly prevalence disorder and
increasing day by day worldwidely. T2DM is a metabolic disorder, which is characterized by …

Despite the advancements in the management of Diabetes mellitus, the design and
synthesis of drug molecule which ameliorates the hyperglycemia and associated secondary …

Abstract Type 2 diabetes (T2D) is a severe disease and it is one of the most raising
problems worldwide. This study deals with design, synthesis and in vivo determination of a …

A small library of new benzothiazole clubbed oxadiazole-Mannich bases (M-1 to M-22) were
synthesized and characterized by IR, NMR, Mass and Elemental analysis results. Molecular …

Nowadays, dipeptidyl peptidase-IV (DPP-IV) is emerging as a hopeful drug target for treating
Type 2 diabetic mellitus (T2DM). Currently marketed DPP-IV inhibitors work by lowering the …

Thiazolines and their derivatives hold significant importance in the field of medicinal
chemistry due to their promising potential as pharmaceutical agents. These molecular …

The limited number of agrochemicals targeting plant bacterial diseases has driven us to
develop highly efficient, low-cost, and versatile antibacterial alternatives. Herein, a novel …

Diabetes mellitus (DM) is a metabolic disease, and diabetes patients have long-term higher
blood sugar levels than standard. Most people with diabetes have complications that greatly …